Trouble reading this email? View it in your browser
European Federation of Pharmaceutical industries and associations
   

EFPIA Newsletter 30 November 2023

 
 
 
   

Discover EFPIA's vision for a healthier, more competitive and resilient Europe

#Imagine if Europe found the treatment to slow Alzheimer’s progression, produced the first vaccine for brain cancer or medicines that could transform the lives of patients with chronic disease. Now we've imagined. Let's take action. 

 
 
 
 
   

Blogs

 

How companies are moving patient voices centre stage
29 November 2023

Innovative pharmaceutical companies can turn patient engagement into an organisational mindset and practice. Focusing... Read more

Capacity building: How can patient organisations shape the future of drug development?
29 November 2023

Patients have a central role to play across the medicine lifecycle – developing the right skills boosts impact and supports... Read more

 
 
 
   

Events

 

European Health Summit 2023
07 December 2023 (Egmont Palace, Brussels)

The 2024-2029 Agenda: The Future of Healthcare in Europe Read more

ACCELERATE 2024 Paediatric Oncology Conference
08 February 2024 (Brussels and virtually)

Join us to advance paediatric oncology drug development. Read more

 
 
 
   

How the pharmaceutical industry is contributing to mitigate climate change

The health of the planet is inherently linked to our personal health. Since 2020, 70% of EFPIA members raised their ambition on climate action targets.

Read Nathalie Moll's September blog post and discover more in our latest report.

 
 
 
 
   

What we are reading

 
Dynamic Regulatory Assessment: Unpacking the Process Reveals Readiness to Pilot for Europe—An...
On 29 November 2023 (clinicaltherapeutics.com)

Dynamic regulatory assessment, a regulatory science concept developed by EFPIA, could drive increased connectedness... Read more

Mario Draghi delivers downbeat outlook for EU economic growth
On 08 November 2023 (Financial Times)

Bloc is falling behind its global counterparts, says former ECB president.

Read more